Photo by nci from unsplash
e16537Background: Although PS is a strong marker of adverse outcomes in most metastatic solid tumors, data of PS status are lacking in GCT, especially using validated scales such as Eastern… Click to show full abstract
e16537Background: Although PS is a strong marker of adverse outcomes in most metastatic solid tumors, data of PS status are lacking in GCT, especially using validated scales such as Eastern Coopera...
Keywords:
status;
performance status;
status advanced;
advanced germ;
germ cell;
cell tumors
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!